How Hyperbaric Oxygen Therapy May Support Tissue Survival After Severe Traumatic Ischemia
A crush injury occurs when sustained or high-energy force damages muscle, blood vessels, nerves, connective tissue, and sometimes bone. The visible wound may represent only part of the injury. Beneath the skin, bleeding, endothelial damage, microvascular obstruction, and progressive edema can reduce tissue perfusion long after the original force has been removed.
As swelling increases, oxygen must travel farther from functioning capillaries to reach injured cells. Rising tissue pressure may further restrict arterial inflow and venous drainage, creating a cycle of edema, ischemia, cellular dysfunction, and additional swelling. Without timely intervention, viable tissue can progress to necrosis, infection, functional loss, or amputation.
Hyperbaric oxygen therapy, or HBOT, may be used as an adjunct in selected crush injuries and other forms of acute traumatic peripheral ischemia. It does not replace trauma resuscitation, vascular repair, fracture stabilization, fasciotomy, or surgical debridement. Its purpose is to increase oxygen availability within threatened tissue while definitive surgical and medical care addresses the underlying injury.
The Undersea and Hyperbaric Medical Society recognizes crush injury, compartment syndrome, and other acute traumatic ischemias as accepted clinical indications for HBOT. Medicare also covers chamber-based HBOT for crush injuries and acute traumatic peripheral ischemia when loss of function, limb, or life is threatened and treatment is used alongside accepted standard measures. (UHMS)
What Happens to Tissue During a Crush Injury?
Crush injuries range from localized hand or foot trauma to extensive limb injuries involving open fractures, disrupted vessels, contaminated wounds, and severe muscle damage.
The initial mechanical force can rupture cells and blood vessels directly. Damaged vessels leak fluid into the surrounding tissue, while clotting, vascular spasm, endothelial swelling, and microthrombi reduce effective circulation. Inflammatory cells then accumulate within the injured area, contributing to additional endothelial dysfunction and fluid leakage.
This can create a self-perpetuating sequence:
- Trauma damages muscle and the microcirculation.
- Bleeding and inflammation increase tissue edema.
- Edema compresses small blood vessels and increases diffusion distance.
- Reduced perfusion produces tissue hypoxia.
- Hypoxic cells lose the ability to regulate fluid and energy normally.
- Cellular swelling and endothelial injury increase edema further.
Even after a damaged artery is repaired or external compression is removed, tissue may remain at risk. Restoration of blood flow can trigger ischemia-reperfusion injury, during which activated leukocytes, inflammatory mediators, and reactive oxygen species contribute to secondary endothelial and cellular damage. (NCBI)
The clinical objective is not merely to restore a palpable pulse. It is to preserve the microcirculation and maintain oxygen delivery at the cellular level.
Crush Injury, Compartment Syndrome, and Crush Syndrome Are Different
These terms are related but should not be used interchangeably.
A crush injury describes direct tissue damage caused by compression or high-energy force. It may remain localized to one body region or involve multiple structures.
Acute compartment syndrome occurs when pressure rises within a closed fascial compartment enough to impair tissue perfusion. It most commonly affects the extremities and represents a surgical emergency. Pain out of proportion to the apparent injury, pain with passive stretch, tense swelling, sensory changes, and motor dysfunction may raise concern, but no single examination finding should be used to exclude the diagnosis.
When acute compartment syndrome is present, urgent fasciotomy is the definitive treatment. HBOT must not be used as an alternative to surgical decompression or as a reason to delay it.
Crush syndrome is a systemic consequence of extensive muscle destruction, often after prolonged compression. When pressure is released, potassium, myoglobin, acids, and other intracellular substances may enter the circulation. The patient can develop hyperkalemia, metabolic acidosis, shock, cardiac arrhythmia, and acute kidney injury.
Crush syndrome requires emergency resuscitation, cardiac and electrolyte monitoring, renal protection, and critical care. HBOT may address threatened local tissue in an appropriately selected patient, but it does not replace management of the systemic metabolic consequences.
How HBOT Increases Oxygen Delivery to Crushed Tissue
During HBOT, the patient breathes oxygen while exposed to increased atmospheric pressure inside a medical hyperbaric chamber. The elevated oxygen partial pressure substantially increases the quantity of oxygen dissolved directly in plasma.
This dissolved oxygen can travel through the remaining functional microcirculation and establish a stronger diffusion gradient between capillary blood and hypoxic tissue. Oxygen may therefore reach viable cells located farther from an intact capillary than it could under ordinary atmospheric conditions.
This effect is particularly relevant when edema and microvascular damage have impaired oxygen delivery without eliminating perfusion completely.
HBOT cannot push blood through a completely obstructed major artery. Vascular disruption, thrombosis, or inadequate arterial inflow still requires urgent vascular evaluation and repair when feasible. Hyperbaric treatment is most biologically plausible when some circulation remains or has been restored, but surrounding tissue continues to be threatened by edema, microvascular dysfunction, or reperfusion injury.
Hyperoxic Vasoconstriction May Reduce Edema
One of the important physiologic effects of HBOT is hyperoxic vasoconstriction. Elevated oxygen tension causes arterioles in certain tissues to constrict, reducing plasma filtration into the injured area.
Ordinarily, vasoconstriction could reduce oxygen delivery. Under hyperbaric conditions, however, plasma contains substantially more dissolved oxygen. Tissue oxygenation can remain elevated even as regional blood flow decreases.
This combination may help reduce edema without worsening local hypoxia. As swelling decreases, pressure on small vessels may fall and the distance between capillaries and viable cells may shorten.
HBOT may also reduce neutrophil adhesion to injured vascular endothelium, potentially limiting part of the inflammatory microvascular obstruction associated with ischemia-reperfusion injury. These mechanisms help explain why HBOT is considered for acute traumatic ischemia rather than simply for the external wound. (NCBI)
HBOT Does Not Replace Fasciotomy or Vascular Repair
A patient with a severe crush injury requires immediate trauma assessment. Priorities may include hemorrhage control, airway and hemodynamic stabilization, vascular examination, fracture management, wound exploration, and evaluation for compartment syndrome.
Urgent interventions may include:
- Surgical decompression through fasciotomy
- Arterial or venous repair
- Thrombectomy or bypass
- Fracture reduction and stabilization
- Debridement of contaminated or nonviable tissue
- Repair or reconstruction of tendons, nerves, and soft tissue
- Replantation of an amputated part
- Antibiotic prophylaxis or treatment
- Tetanus prevention
- Management of rhabdomyolysis and electrolyte abnormalities
Emergency surgical treatment should generally occur before HBOT when delay would threaten the limb or patient. Hyperbaric therapy and surgery are complementary, not competing, interventions. Current clinical reviews emphasize that revascularization, fracture stabilization, and necessary decompression should precede hyperbaric treatment when urgently indicated. (NCBI)
HBOT should also never be used to avoid necessary debridement. Tissue that is irreversibly necrotic can become a focus for infection and must be managed surgically.
Which Crush Injuries May Be Considered for HBOT?
Not every contusion, fracture, or soft-tissue injury requires hyperbaric treatment. HBOT is generally considered when the injury threatens meaningful tissue, limb function, or survival.
Potential candidates may include patients with:
- Severe soft-tissue crush injury and progressive edema
- Acute traumatic peripheral ischemia
- High-grade open fractures with substantial soft-tissue damage
- Persistent tissue hypoxia after vascular repair
- Compartment syndrome after appropriate surgical decompression
- Replanted or revascularized extremities with threatened viability
- Extensive hand or foot injuries in which small areas of tissue loss could cause major functional impairment
- Traumatic wounds with a high risk of necrosis, infection, or reconstructive failure
- Compromised tissue in a patient with diabetes, vascular disease, tobacco exposure, or other host factors that limit healing
Patient selection should involve direct communication between the trauma, orthopedic, vascular, plastic or hand surgery, and hyperbaric teams.
The presence of normal large-vessel pulses does not always mean the tissue is safe. A limb can have macroscopic arterial flow while the microcirculation remains impaired. Conversely, HBOT cannot compensate for an unrepaired major vascular injury.
Clinical assessment may include serial examination, Doppler evaluation, vascular imaging, compartment-pressure measurement when appropriate, laboratory testing, tissue appearance, and direct operative findings. Transcutaneous oxygen measurements may provide additional information in selected cases, although they should not delay necessary treatment.
Timing of HBOT After a Crush Injury
When HBOT is selected, treatment is generally most relevant during the early period when tissue is hypoxic but still viable.
The objective is to intervene before progressive edema, microvascular failure, and cellular injury become irreversible. Treatment should be coordinated promptly after stabilization and necessary surgery rather than reserved automatically for a wound that has already declared extensive necrosis.
European consensus recommendations support early HBOT as an adjunct to surgery for open fractures with crush injury. A current clinical review similarly emphasizes early assessment and close coordination between the surgical and hyperbaric teams. (PubMed Central (PMC))
Timing still depends on the individual patient. HBOT should not interrupt active resuscitation, delay vascular repair, postpone fasciotomy, or prevent a necessary return to the operating room.
What a Hyperbaric Treatment Course May Involve
Protocols vary according to the injury, surgical findings, chamber capability, and patient stability.
Clinical studies have used pressures around 2.4 to 2.5 atmospheres absolute with approximately 90 minutes of oxygen exposure per session. Treatments may be delivered twice daily during the early phase of a severe injury and then reduced as edema, perfusion, and tissue viability improve.
The 1996 randomized trial of crush injuries used 12 sessions delivered twice daily over six days after surgical management. The more recent Hyperbaric Oxygen for Lower Limb Trauma trial evaluated a planned course of 12 treatments at approximately 2.4 ATA, beginning within 48 hours of injury. These study protocols provide clinical context, but they should not be treated as a universal prescription for every crush injury. (PubMed)
Treatment planning should account for:
- Timing of repeat surgical exploration
- Vascular and neurologic status
- Compartment decompression
- Fracture stability
- Wound contamination
- Ventilation and critical care needs
- Intravenous medications and blood products
- Glucose management
- Chest injuries and pneumothorax risk
- Implanted or external medical devices
- The patient’s ability to equalize middle-ear pressure
The limb should be reassessed throughout the course. HBOT should not continue automatically when tissue is deteriorating or a surgical problem remains unresolved.
Evidence for HBOT in Crush Injury
The clinical evidence is smaller than the evidence base for many common trauma interventions, but randomized and observational studies suggest potential benefit in selected severe injuries.
A double-blind randomized trial published in 1996 included 36 patients with crush injuries who received either HBOT or sham treatment after surgery. Complete healing was reported more frequently in the HBOT group, and patients receiving HBOT required fewer repeat surgical procedures. The study was small, and some of its subgroup analyses were not prespecified, so its findings should be interpreted with appropriate caution. (PubMed)
The international HOLLT randomized trial enrolled 120 patients with open tibial fractures and severe soft-tissue injury. Its combined primary outcome of necrosis or infection within 14 days was not statistically different between the assigned groups. Tissue necrosis considered separately occurred in 29 percent of patients assigned to HBOT and 53 percent of controls. The investigators also reported fewer late complications and better functional outcomes in the HBOT group. (ResearchGate)
These findings are encouraging, but they do not establish that HBOT is necessary or effective for every traumatic limb injury. Trauma mechanisms, wound severity, surgical quality, treatment timing, and actual HBOT exposure vary considerably among studies.
The most defensible role remains adjunctive treatment for carefully selected, limb-threatening acute traumatic ischemia within a multidisciplinary trauma system.
Monitoring Tissue Viability During Treatment
The response to HBOT should be evaluated alongside the overall surgical course. Clinicians may monitor:
- Skin color and temperature
- Capillary refill
- Doppler signals and palpable pulses
- Edema and tissue tension
- Sensory and motor function
- Wound bleeding and tissue appearance
- Development or progression of necrosis
- Infection and drainage
- Need for additional debridement
- Viability of replanted or reconstructed tissue
- Renal function, creatine kinase, potassium, and urine output when muscle injury is extensive
Improvement may appear as stabilization of tissue margins, decreased swelling, improved wound-bed appearance, or clearer demarcation between viable and nonviable tissue.
A concerning examination should trigger surgical reassessment rather than simply an additional chamber session. Progressive pain, tense swelling, neurologic deterioration, absent flow, systemic toxicity, or advancing necrosis may indicate a problem that requires urgent operative intervention.
Risks and Logistical Challenges
HBOT is generally well tolerated in appropriately screened patients, but acute trauma introduces additional complexity.
Potential HBOT complications include middle-ear barotrauma, sinus pressure injury, temporary visual changes, oxygen toxicity, and rare oxygen-induced seizure. An untreated pneumothorax is generally considered an absolute contraindication.
Trauma patients may also have pulmonary contusions, chest tubes, unstable fractures, mechanical ventilation, vascular access devices, external fixation, drains, or continuous infusions. Each device and treatment must be assessed for pressure compatibility and fire safety.
Safe treatment of a critically ill trauma patient requires:
- Chamber-compatible monitoring and support equipment
- Personnel trained in hyperbaric critical care
- Reliable communication with the patient and treatment team
- A plan for deterioration under pressure
- Rapid access to surgery and intensive care
- Coordination of analgesia, sedation, ventilation, and glucose management
These requirements can limit the practicality of HBOT even when a physiologic rationale exists. Transfer to a hyperbaric facility should not expose an unstable patient to greater risk or separate the patient from essential surgical care.
Limb Salvage Includes Long-Term Function
Survival of the limb is not the only outcome that matters. Severe crush injuries can produce chronic pain, sensory loss, muscle weakness, stiffness, contracture, infection, delayed bone healing, and repeated reconstructive procedures.
A technically preserved extremity may still have limited function. Conversely, amputation may occasionally offer a better functional path than prolonged attempts to preserve severely damaged tissue. These decisions require honest, patient-centered discussion among the trauma, reconstructive, rehabilitation, prosthetic, and hyperbaric teams.
When HBOT is used, its purpose should be clearly defined. The goal may be to preserve muscle, limit necrosis, support a replantation, improve the reconstructive options available to the surgeon, or reduce the extent of tissue loss.
For patients and families, the period after a severe crush injury can be frightening and uncertain. Clear explanations are essential. HBOT should be presented neither as a rescue that guarantees limb survival nor as an experimental afterthought. It is a time-sensitive adjunct that may help protect viable tissue when integrated appropriately with surgery, vascular care, critical care, and rehabilitation.
